Precision BioSciences, Inc. (NASDAQ: DTIL) shares are trading higher Tuesday after the company announced it has signed a licensing agreement wit

Related Keywords

Michael Amoroso , Azercabtagene Zapreleucel , Precision Biosciences Inc , Tg Therapeutics Inc , , Benzinga Pro ,